Gene · 27329
Papers2,231
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,231
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Features of Lipid Disorders in Cardiovascular-Kidney-Metabolic Syndrome. | Int J Mol Sci | 2026 | 42794744 | PubTator, text mining | PubMed |
| The Role of Angiopoietin-Like Proteins 3 and 4 and Their Target Lipases in CKD: A Drug-Target Mendelian Randomization Study. | Am J Kidney Dis | 2026 | 42772348 | PubTator, text mining | PubMed |
| Association of circulating ANGPTL3 level with all-cause and cardiovascular mortality. | Int J Cardiol Cardiovasc Risk Prev | 2026 | 42761856 | PubTator, text mining | PubMed |
| CRISPR therapy for dyslipidemia. | Curr Opin Lipidol | 2026 | 42755348 | PubTator, text mining | PubMed |
| Evinacumab Across Different Lipid Phenotypes: A Systematic Review and Meta-Analysis. | Adv Ther | 2026 | 42742892 | PubTator, text mining | PubMed |
Expectations for Angiopoietin-like 3 Inhibitors Taking Broad Lipid-modifying Effects on the Comprehensive Control of Atherosclerotic Cardiovascular Disease Risk in Patients with Homozygous Familial Hypercholesterolemia. | J Atheroscler Thromb | 2026 | 42732948 | PubTator, text mining | PubMed |
| Efficacy and Safety of Quarterly Dosing SHR-1918 in Patients With Suboptimally Controlled Hyperlipidemia. | JACC Asia | 2026 | 42714362 | PubTator, text mining | PubMed |
| Precision genome editing strategies for enduring lipid lowering in atherosclerosis. | Eur J Pharmacol | 2026 | 42692283 | PubTator, text mining | PubMed |
| Durability of CRISPR-Cas9 Gene Editing Targeting ANGPTL3 with CTX310. | N Engl J Med | 2026 | 42663980 | PubTator, text mining | PubMed |
| Hypocholesterolemia in liver and cardiovascular disease: Friend or foe? | J Intern Med | 2026 | 42657470 | PubTator, text mining | PubMed |
| Discovery of functional variants regulating lipid metabolism in an East Asian population. | Metabolism | 2026 | 42636954 | PubTator, text mining | PubMed |
| Osteoactivin/GPNMB as a candidate biomarker of diabetic nephropathy in type 2 diabetes: associations with angiogenic and kidney injury biomarkers. | Front Endocrinol (Lausanne) | 2026 | 42625696 | PubTator, text mining | PubMed |
| Clinical Benefits Associated With Evinacumab in Pediatric Patients With Homozygous Familial Hypercholesterolemia. | J Am Heart Assoc | 2026 | 42622232 | PubTator, text mining | PubMed |
| Injectable Lipid-Lowering Therapies in Advanced Chronic Kidney Disease: Efficacy, Safety and the Dialysis Paradox. | Cardiovasc Drugs Ther | 2026 | 42603236 | PubTator, text mining | PubMed |
| Novel triglyceride-lowering therapies to reduce the risk of acute pancreatitis in hypertriglyceridaemia: a protocol for systematic review and meta-analysis. | BMJ Open | 2026 | 42601105 | PubTator, text mining | PubMed |
| Decoding Primary Hyperlipoproteinemias: A Focus on the Pathogenesis and Diagnosis of Familial Hypercholesterolemia and Familial Combined Hyperlipidemia. | Diagnostics (Basel) | 2026 | 42587551 | PubTator, text mining | PubMed |
| Gene Therapy for Lipid Management: Dawn of a New Era. | Cureus | 2026 | 42582720 | PubTator, text mining | PubMed |
| Reduced Circulating Angiopoietin-Like Protein Levels in Crimean-Congo Hemorrhagic Fever. | APMIS | 2026 | 42575869 | PubTator, text mining | PubMed |
| Circulating proteins altered in response to the Dietary Approaches to Stop Hypertension (DASH) diet suggest underlying molecular mechanisms and long-term health benefits. | medRxiv | 2026 | 42539060 | PubTator, text mining | PubMed |
| Angiopoietins and Angiopoietin-Like Proteins as New Biomarkers in Posttransplant Diabetes Mellitus: A Single-Center Study From Kuwait. | Exp Clin Transplant | 2026 | 42538711 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/27329/papers